Woriheal Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac (100mg), Paracetamol (325mg), and Trypsin Chymotrypsin (100000 AU). Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), effectively reduces inflammation and pain by inhibiting cyclooxygenase enzymes, thereby decreasing prostaglandin synthesis. Paracetamol provides analgesic and antipyretic effects through central inhibition of prostaglandin synthesis, complementing Aceclofenac’s peripheral action. Trypsin Chymotrypsin, a proteolytic enzyme complex, aids in reducing inflammation and edema by promoting the breakdown of inflammatory mediators and fibrin deposits, facilitating faster tissue repair. This synergistic combination is indicated for the management of acute and chronic musculoskeletal disorders, including osteoarthritis, rheumatoid arthritis, postoperative pain, and soft tissue injuries. Woriheal Tablet offers effective relief from pain, swelling, and inflammation, enhancing patient mobility and comfort. It should be used under medical supervision, with caution in patients with gastrointestinal, hepatic, or renal impairment. Common adverse effects may include gastrointestinal discomfort, nausea, or hypersensitivity reactions. Contraindications include known hypersensitivity to any component, active peptic ulcer, or severe hepatic or renal dysfunction. Woriheal Tablet provides a balanced approach to pain and inflammation management, optimizing therapeutic outcomes in musculoskeletal conditions.